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Cardiac Function and Heart Failure
1108-126 The Effect of Physical Exercise on Circulating 
Chromogranin A Levels in Patients With Congestive 
Heart Failure
Mette Elise Estensen, Aina Hognestad, Unni Syversen, Torbjorn Omland, Akershus 
University Hospital, Nordbyhagen, Norway, Rikshospitalet, Oslo, Norway
Background: Chromogranin A (CgA) is widely distributed throughout the neurendocrine
system and may, due to its long in vivo and in vitro half-life, be an attractive candidate for
assessment of neuroendocrine activity in congestive heart failure (CHF). Recently,
increased plasma levels of CgA have been found in patients with CHF and related to the
severity of symptoms and prognosis. The effect of physical exercise on circulating CgA
levels in patients with CHF is unknown. Moreover, the relation between CgA levels and
invasive hemodynamic indices remains to be established.
Methods: 22 patients with chronic CHF (NYHA class II- IV) performed supine bicycle test-
ing with breath-to-breath analysis for assessment of peak oxygen uptake (VO2 max).
Venous blood samples for CgA analysis were drawn at baseline, at peak exercise, and 1
hour post-exercise. Plasma levels of CgA were determined by radioimmunoassay.
Echocardiography and left-and right cardiac catheterization were performed in all
patients. 10 healthy age- and sex matched volunteers served as controls.
Results: CHF patients had reduced peak VO2 compared to controls (13.6 ± 5.4 vs 31.5 ±
10.0 ml/kg/min, p<0.001). The baseline level of CgA was elevated in patients compared
to controls (24.3 ± 14.4 vs. 18.7 ± 1.5 ng/ml, p< 0.05). Baseline levels of CgA correlated
positively with arteriovenous O2 difference (r = 0.62, p = 0.02) and negatively with LVEF (r
= -0.70, p< 0.001). CgA did not correlate significantly with pulmonary capillary wedge
pressure, right atrial pressure, stroke volume, cardiac index or peak VO2. Whereas CgA
levels increased significantly from baseline to peak exercise in control subjects (from
18.7 ± 1.5 to 22.0 ± 3.6 ng/ml, p< 0.05), the CgA response to exercise was blunted in
CHF patients (from 24.3 ± 14.4 to 24.4 ± 15.6 ng/ml, p = ns).
Conclusion: CgA levels are elevated in patients with CHF and are related to left ventricu-
lar systolic function and arteriovenous O2-difference. The CgA response to exercise is
blunted in CHF, suggesting widespread baseline neuroendocrine activation in CHF. In
contrast to catecholamines, circulating CgA concentrations are not affected by physical
activity in patients with CHF.
1108-127 Determinants of Exercise Capacity in Hypertrophic 
Cardiomyopathy Are Different in Patients With or 
Without Heart Failure
Cinzia Cianfrocca, Francesco Pelliccia, Antonio Auriti, Gerardo Ansalone, Vincenzo 
Guido, Paride Giannantoni, Antonino Granatelli, Giuseppe Richichi, Massimo Santini, 
San Filippo Neri Hospital, Rome, Italy
Background: Mechanisms of exercise intolerance have been previously studied in hyper-
trophic cardiomyopathy (HC), but have yielded conflicting results. Aim of this study was to
ascertain whether determinants of exercise capacity differ in HC pts with or without
symptoms and signs of heart failure.
Methods: We studied 25 HC pts (15 males, age: 43±7 yrs, Gr.A) with functional class I
and normal LV function (i.e. baseline LV ejection fraction>50%), as well as 10 HC pts (6
males, age: 45±8 yrs, Gr.B) with functional classes II or III and LV dysfunction (i.e. base-
line LV ejection fraction<50%). All pts underwent symptom-limited supine bicycle exer-
cise (25 watt every 2 minutes) with post-exercise Doppler echocardiography. Exercise
duration ranged from 180 to 610 s (mean: 480±223 s).
Results: Both in Gr.A and in Gr.B, no relation was found between exercise time and mea-
surements of cardiac morphology (i.e. maximal LV wall thickness: r=0.05 and r=0.09,
respectively; LV wall thickness index: r=-0.11 and r=0.03; RV end-diastolic diameter: r= -
0.17 and r=0.13; LV end-diastolic diameter: r= 0.21 and r=0.29), cardiac function at rest
(i.e. RV ejection fraction: r=0.22 and r=0.15; LV ejection fraction: r=0.27 and r=0.23), and
Doppler indexes of LV diastolic filling (i.e. peak E-wave: r=-0.21 and r=0.25; peak E-wave:
r=-0.09 and r=-0.15; E/A ratio: r=0.16 and r=0.25). Multivariate analysis showed that the
only independent predictors of exercise capacity were: (i) in Gr.A, the extent of changes
recorded at peak exercise in LV ejection fraction (p=0.01) and LV end-diastolic volume
(p=0.02); (ii) in Gr.B, the extent of changes recorded at peak exercise in RV ejection frac-
tion (p=0.01).
Conclusion: Determinants of exercise capacity in HC are different in pts with or without
symptoms and signs of heart failure. In asymptomatic pts with normal LV function, exer-
cise tolerance relates to the ability of the LV to increase its volume with exercise in order
to augment LV ejection fraction. In pts with mild-to-moderate heart failure and LV systolic
dysfunction, conversely, exercise capacity depends on a preserved RV function, which
can maintain an adequate pre-load on exercise.
1108-128 Myocardial Stunning in Hypertrophic Cardiomyopathy Is 
Associated With Progression to Mild-to-Moderate Heart 
Failure
Francesco Pelliccia, Cinzia Cianfrocca, Christian Pristipino, Vincenzo Pasceri, Antonino 
Granatelli, Antonio Auriti, Massimo Santini, Giuseppe Richichi, San Filippo Neri Hospital, 
Rome, Italy
Background: Myocardial stunning can occur in multiple cardiac diseases and has been
previously observed even in pts with hypertrophic cardiomyopathy (HC). Recently, the
phenomenon has been related to progressive deterioration in LV function in ischemic
heart disease. Aim of this study was to test the hypothesis that the progression to heart
failure in HC pts is associated with myocardial stunning.
Methods: We studied a total of 30 pts with nonobstructive HC (mean age: 45±12 years),
no heart failure, normal coronary angiograms, and normal LV function at baseline but
with no exercise-induced increase in LV ejection fraction. All pts underwent, off-drugs,
two consecutive symptom-limited bicycle exercise tests (i.e. workload increase of 25
watts every 2 min), one-hour apart. Doppler echocardiography was performed at base-
line, at peak exercise, and every 30 min after each test, and LV ejection fraction and Dop-
pler measurements of LV diastolic filling were derived. Myocardial stunning was
diagnosed if a more prolonged deterioration in LV systolic and diastolic function was
detected after repetitive exercise than after the initial exercise test.
Results: At baseline, myocardial stunning was seen in 10 pts (Gr.A) but not in the
remaining 20 pts (Gr.B). Compared with Gr.B, Gr.A pts were significantly older (56±14 vs
45±15 years, p<0.05), had higher maximal LV wall thickness (22±5 vs 17±6 mm, p<0.05),
and lower LV ejection fraction (58±8 vs 68±10%, p<0.05). Over a 5-year follow-up period,
symptoms of mild-to-moderate heart failure developed in 7/10 Gr.A pts (70%) and in 4/20
Gr.B pts (20%). Progressive LV function deterioration (i.e. decrease of ejection
fraction10%) occurred in 3 and 2 Gr.A pts, respectively, but were not observed in Gr.B.
Conclusion: Our results confirm that significant myocardial stunning can occur in a sub-
set of pts with HC and is associated with worse functional status and outcome. Repetitive
episodes of myocardial ischemia during daily life may play a previously unrecognized
pathophysiologic role in determining the progression to mild-to-moderate heart failure in
HC.
1108-129 Left Atrial Enlargement in Hypertrophic 
Cardiomyopathy: The Importance of Left Ventricular 
Hypertrophy and Diastolic Dysfunction
Hua Yang, Anna Woo, Michal Jamorski, Katie Fedwick, Daniel Monakier, E. Douglas 
Wigle, Harry Rakowski, University Health Network, Toronto General Hospital, Toronto, 
ON, Canada
Background:Left atrial (LA) enlargement (LAE) in patients (Pts) with hypertrophic cardi-
omyopathy (HCM) is associated with increased morbidity and mortality. We analyzed fac-
tors related to LAE.
Methods: 84 pts with HCM were divided into two groups based on the anteroposterior
LA diameter measured by 2D echo: Group A (n=30) with LA < 40mm and Group B (n=54)
with LA >40mm. Left ventricular (LV) wall thickness (LVWT, mm) was measured at 15
sites of LV wall segments: 5 walls (anterior and posterior septal, anterior, lateral, poste-
rior) at 3 levels (base, mid and apex). Mitral peak filling velocity and tissue Doppler (TDI)
peak velocity at lateral annulus (E’, both cm/s), basal septal (IVS, mm), average LVWT of
15 sites (Avg-LVWT, mm), and LV outflow tract rest pressure gradient (LVOT-PG, mmHg)
were measured. Wigle hypertrophy point score (0-10), E/E’ and TDI derived LA pres-
sure(mmHg) were calculated.
Results: Both groups had a similar degree LVOT-PG (14±17 vs 21±24, p<0.05) and syn-
cope (30% vs. 27%, p>0.05). Patients with larger LA had a worse functional class
(NYHA), a higher prevalence of atrial fibrillation (AF) and more LV hypertrophy with
greater LVWT in all non-apical wall segments (p<0.05 to p<0.0005). LAP, IVS, Avg-LVWT,
Wigle score and E/E’ differed between the two groups.
Conclusions: In pts with HCM, LAE is associated with worsened clinical status and
quantitative echo demonstrated more severe LV hypertrophy in all non-apical segments
and more severe diastolic dysfunction with elevated filling pressures.
1108-130 Granulocyte-Colony Stimulating Factor Mobilizes Bone 
Marrow Stem Cells and Favorably Alters Cytokine 
Profile in Patients With Advanced Heart Failure
Jacob Joseph, Asem Rimawi, Paulette Mehta, Michele Cottler-Fox, Anjan Sinha, 
Balkrishna Singh, Rebecca Pacheco, Eugene Smith, III, Jawahar L. Mehta, University of 
Arkansas for Medical Sciences, Little Rock, AR, Central Arkansas Veterans Healthcare 
System, Little Rock, AR
Background: Recent reports indicate that stem cell mobilization with granulocyte-colony
stimulating factor (G-CSF) leads to repair of the infarcted myocardium in animal models.
We conducted a phase I/II study of G-CSF in advanced heart failure patients to deter-
mine if bone marrow stem cells could be safely mobilized in this group of patients.
Methods: Patients with advanced heart failure (n=6; mean age 63±4.2 years; range 54-
82 years; New York Heart Association Class IIIB) with previously implanted defibrillators
were admitted to the General Clinical Research Center for the duration of G-CSF admin-
istration (5 µg/kg/day for 5 days),and serial measurents of stem cell and cytokine
response were done, in additon to safety parameters.
Results: Peripheral stem cell count increased in all patients above the predetermined effi-
cacy parameter of 10 cells/µl. The mean stem cell count increased from 3.6±0.5/µl to
37±13/µl (p=0.022), with a parallel increase in WBC count from 7±1 x 103/ mm3 to 42±8
x 103/mm3 (p=0.002). There was no significant change noted in the plasma levels of IFN-
γ, TNF-α, IL-2 and IL-4. Interestingly, plasma IL-10 level increased from a baseline mean
value of 4.24+/- 0.38 pg/ml to a mean peak value of 9.36 +/- 1.13 pg/ml (p=0.003) by 10
days after initiation of study drug administration, and came down to baseline by 6
weeks.There was an asymptomatic reversible elevation of alkaline phosphatase in all
patients. In one patient, worsening heart failure and renal dysfunction developed, which
was rapidly reversible.
Conclusions: In spite of severe heart failure, there was significant mobilization of stem
cells into the peripheral circulation with a low dose of G-CSF. In addition, G-CSF favor-
ably altered serum cytokine profile in advanced chronic heart failure, with an increase in
the anti-inflammatory cytokine IL-10, and unaltered levels of pro-inflammatory cytokines
Table: *p<0.05, **p<0.001 compared between the two groups
NYHA AF(%) Scores IVS Avg-
LVWT
LAP E' E/E'
LA<40 1.4±0.6 0 3.9±2.1 16.3±3.4 11.7±1.7 11.6±3.1 9.6±2.8 7.6±2.4
LA>40 1.8±0.8
*
17* 6.2±2.1*
*
20.5±5.0*
*
14.0±2.5*
*
14.8±7.0
*
8.0±2.8
*
10.2±5.6
*
